PT782441E - Controlo farmaceutico da inflamacao - Google Patents

Controlo farmaceutico da inflamacao

Info

Publication number
PT782441E
PT782441E PT95932094T PT95932094T PT782441E PT 782441 E PT782441 E PT 782441E PT 95932094 T PT95932094 T PT 95932094T PT 95932094 T PT95932094 T PT 95932094T PT 782441 E PT782441 E PT 782441E
Authority
PT
Portugal
Prior art keywords
control
inflammation
pharmaceutical
oxygenase
inflammation control
Prior art date
Application number
PT95932094T
Other languages
English (en)
Inventor
Dean Willis
Adrian Richard Moore
Derek Albert Willoughby
Original Assignee
Negma Lerads
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4154382&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT782441(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Negma Lerads filed Critical Negma Lerads
Publication of PT782441E publication Critical patent/PT782441E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Mirrors, Picture Frames, Photograph Stands, And Related Fastening Devices (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Rear-View Mirror Devices That Are Mounted On The Exterior Of The Vehicle (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT95932094T 1994-09-22 1995-09-22 Controlo farmaceutico da inflamacao PT782441E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002132690A CA2132690A1 (en) 1994-09-22 1994-09-22 Control and modulation of inflammatory response in humans in need of such control and modulation

Publications (1)

Publication Number Publication Date
PT782441E true PT782441E (pt) 2003-07-31

Family

ID=4154382

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95932094T PT782441E (pt) 1994-09-22 1995-09-22 Controlo farmaceutico da inflamacao

Country Status (12)

Country Link
EP (1) EP0782441B1 (pt)
JP (1) JPH10506388A (pt)
CN (1) CN1213742C (pt)
AT (1) ATE233551T1 (pt)
AU (1) AU3528195A (pt)
CA (1) CA2132690A1 (pt)
DE (1) DE69529831T2 (pt)
DK (1) DK0782441T3 (pt)
ES (1) ES2192205T3 (pt)
NZ (1) NZ292963A (pt)
PT (1) PT782441E (pt)
WO (1) WO1996009038A2 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127356A (en) 1993-10-15 2000-10-03 Duke University Oxidant scavengers
US5756492A (en) * 1996-09-09 1998-05-26 Sangstat Medical Corporation Graft survival prolongation with porphyrins
DE69813898T2 (de) 1997-11-03 2004-03-11 Duke University Substituierte porphyrinen
WO1999055388A1 (en) 1998-04-24 1999-11-04 Duke University Substituted porphyrins
CA2355066A1 (en) 1998-12-17 2000-06-22 Sangstat Medical Corporation Extending graft survival by heme oxygenase-i expression induced immunomodulation
DE60024588T2 (de) 1999-01-25 2006-08-17 National Jewish Medical And Research Center, Denver Substituierte porphyrine und deren therapeutische verwendungen
WO2002098431A1 (en) 2001-06-01 2002-12-12 National Jewish Medical And Research Center Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance
CN1646140A (zh) 2002-02-04 2005-07-27 阿尔法玛药品研发有限公司 可释放co的化合物在用于治疗炎症药物的制备中的应用
US8097585B2 (en) 2002-04-15 2012-01-17 Beth Israel Deaconess Medical Center, Inc. Methods of treating inflammation by administration of heme oxygenase-1 and products of heme degradation
WO2003103680A1 (en) 2002-06-07 2003-12-18 Duke University Substituted porphyrins
FR2842738B1 (fr) * 2002-07-23 2006-02-10 Negma Lerads Utilisation d'une rheine pour la preparation d'un medicament pour le traitement de l'inflammation chronique, la prevention et le traitement du rejet des transplantations d'organes et de tissus
WO2007041525A2 (en) * 2005-09-30 2007-04-12 Ovation Pharmaceuticals, Inc. Method of treating pancreatitis
MX2010012593A (es) 2008-05-23 2011-03-04 Nat Jewish Health Metodos para el tratamiento de lesion asociada con exposicion a especie alcalina.
WO2011103018A1 (en) * 2010-02-18 2011-08-25 High Point Pharmaceuticals, Llc Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
ES2656237T3 (es) 2011-04-19 2018-02-26 Alfama, Inc. Moléculas liberadoras de monóxido de carbono y usos de las mismas
JP6134710B2 (ja) 2011-07-21 2017-05-24 アルファーマ インコーポレイテッドＡｌｆａｍａ，Ｉｎｃ． 一酸化ルテニウム放出分子およびその使用
CN105727379A (zh) * 2016-02-25 2016-07-06 顾宇春 血红素加氧酶药物洗脱支架
CN110585215B (zh) * 2019-09-19 2023-06-02 中山大学 氯化血红素及其复合物在医药中的新应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5010073A (en) * 1989-10-05 1991-04-23 The Rockefeller University Use of liposomes as carriers for metalloporphyrins
US5102670A (en) * 1990-09-14 1992-04-07 Abraham Nader G Method for treating eye disorders by reducing 12(r)-hydroxyeicosatetraenoic acid and 12(r)-dihydroxyeicosatrienoic acid levels
WO1992018112A1 (en) * 1991-04-19 1992-10-29 The Children's Medical Center Corporation Method of preventing nmda receptor complex-mediated neuronal damage
EP0605622B1 (en) * 1991-09-24 1997-11-12 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Oxygen substituted derivatives of nucleophile-nitric oxide adducts as nitric oxide donor prodrugs
GB9127376D0 (en) * 1991-12-24 1992-02-19 Wellcome Found Amidino derivatives
GB9200114D0 (en) * 1992-01-04 1992-02-26 Scras Dual inhibitors of no synthase and cyclooxygenase
EP0673236A4 (en) * 1992-12-10 1999-07-07 Hemogen Inc METHOD FOR STIMULATING THE PRODUCTION OF HEM OXYGENASE USING VITAMIN B12.

Also Published As

Publication number Publication date
DE69529831D1 (de) 2003-04-10
DE69529831T2 (de) 2003-12-24
ES2192205T3 (es) 2003-10-01
WO1996009038A3 (en) 1996-06-13
CN1213742C (zh) 2005-08-10
EP0782441B1 (en) 2003-03-05
AU3528195A (en) 1996-04-09
JPH10506388A (ja) 1998-06-23
WO1996009038A2 (en) 1996-03-28
NZ292963A (en) 2001-06-29
CN1166785A (zh) 1997-12-03
CA2132690A1 (en) 1996-03-23
EP0782441A1 (en) 1997-07-09
ATE233551T1 (de) 2003-03-15
DK0782441T3 (da) 2003-06-30

Similar Documents

Publication Publication Date Title
PT782441E (pt) Controlo farmaceutico da inflamacao
DE69739656D1 (de) 1 inhibitor und hyaluronan als polymer mit verzögerter wirkstofffreigabe
ATE135231T1 (de) Verwendung von ''cartilage-inducing factor'' (cif) zur behandlung von hemato- oder lymphopoietischen krankheiten
CA2105529A1 (en) Composition comprising non-steroidal anti-inflammatory agent and effectively non-antibacterial tetracycline
MX9308199A (es) Inhibidores de enzima.
AU8165982A (en) 4-aminosalicylic acid as an anti-inflammatory agent
CA2262847A1 (en) Acylpyrroldicarboxylic acids and acylindoldicarboxylic acids and their derivatives and inhibitors of the cytosolic phospholipase a2
NO20002440D0 (no) Hydroksam- og karboksylsyrederivater med MMP- og TNF- inhiberende aktivitet
ES2171543T3 (es) Composiciones administrables topicamente que contienen derivados del acido 3-benzoilfenilacetico para el tratamiento de trastornos inflamatorios oftalmicos.
DE69620458D1 (de) Benzofuran-carboxamide und -sulfonamide
DK0869965T3 (da) Steroidnitritesterderivater anvendelige som antiinflammatoriske lægemidler
ATE270100T1 (de) Ibuprofenthioester als hemmer der nf-kappa b abhängigen bildung von mediatoren von entzündung und schmerz
DE69727583D1 (de) Vermeidung von gastrointestinaler schädigung
DE3773059D1 (de) Ester von salsalat mit guajakol zur behandlung von phlogistischen bronchopneumopathien.
ES2161293T3 (es) Derivados de enol acilados como profarmacos de inhibidores de la elastasa.
HUP9902417A2 (hu) Alfa-ketoészterek, és alfa-ketoamidok acilezett enol-származékai
DK0673646T3 (da) Anvendelse af deoxyspergualin til fremstilling af et lægemiddel til behandling af inflammatorisk-hyperreaktive sygdomme
NO901920D0 (no) Nye polypeptidforbindelser.
ITMI922657A1 (it) Composizione terapeutica per uso rettale a base di flunisolide e/o dei relativi esteri per il trattamento di disordini intestinali a carattere infiammatorio
ATE232849T1 (de) 4-phenyl-3-substituierte 1,4-dihydropyridinester mit cerebraler aktivität
DK1017377T3 (da) Anvendelse af 6,7-substituerede 2-aminotetraliner til behandling af af cytokin fremkaldte inflammatoriske tilstande
FR2690344B1 (fr) Compositions therapeutiques a dosage topique dans le traitement effectif de la psoriasis.
IT8819447A0 (it) Composizione di composti che migliorano l'attivita' analgesica, antipiretica e antinfiammatoria.
UA19222A (uk) Спосіб лікуваhhя стеhокардії
UA32151A (uk) Склад для лікування псоріазу